Ernesto Bertarelli
Chairman at Bertarelli & Cie
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Todd Tuckner | M | 59 | 20 years | |
| Georges Muller | M | 84 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland.
Bertarelli & Cie
| 16 years |
| Stefan Mario Meister | M | 58 |
Waypoint Capital Holdings (Jersey) Ltd.
 Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | - |
| Markus U. Diethelm | M | 66 | 16 years | |
| Josef Stadler | M | 61 | 15 years | |
| Rodolfo Bogni | M | 77 |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | - |
| Cyrus Jilla | M | - |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | 4 years |
| Elias Zerhouni | M | 72 |
Waypoint Capital Holdings (Jersey) Ltd.
Waypoint Capital Holdings (Jersey) Ltd. Investment ManagersFinance Waypoint Capital Holdings (Jersey) Ltd. operates as a holding company. The company is headquartered in St. Helier, Jersey. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| François Naef | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 years |
| Robert Mills | M | 74 | 10 years | |
| Sally T. Bott | F | 74 | 3 years | |
| Thomas Naratil | M | 62 | 20 years | |
| Rainer-Marc Frey | M | 61 | 6 years | |
| Helmut Gunter Wilhelm Panke | M | 77 | 11 years | |
| Bruno Gehrig | M | 77 | 4 years | |
| Kathryn L. Biberstein | F | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 7 years |
| Kaspar Villiger | M | 83 | 3 years | |
| Reto Erdin | M | 54 | 3 years | |
| John Jenkins | M | 66 | 12 years | |
| Karin Schmidt | F | 51 | 16 years | |
| Roland Baumann | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 16 years |
| Peter Anton Joseph Kurer | M | 74 | 8 years | |
| Paul H. Arni | M | 60 | 15 years | |
| Michel Demaré | M | 67 | - | |
| Yong Hao Pu | M | 66 | 11 years | |
| Peter Voser | M | 64 | 5 years | |
| Patrick Bont | M | 49 | 4 years | |
| Adam Deutsch | M | 37 | 1 years | |
| Thomas Michael Pixner | M | - | 5 years | |
| António Carlos Custódio de Morais Varela | M | 67 | 9 years | |
| Peter Ding | M | 57 | 6 years | |
| John Katzenmeyer | M | - | 6 years | |
| Lukas Hoppe | M | - | 7 years | |
| Stephan Kirschbaum | M | 57 | 4 years | |
| Tat Pun Ng | M | 79 | 5 years | |
| Gerhard Wilhelm Fusenig | M | 60 | 9 years | |
| Beat Oberlin | M | 69 | 10 years | |
| Jürg Zeltner | M | 57 | - | |
| Ulrich Körner | M | 61 | 10 years | |
| Matthew Engler | M | - | 4 years | |
| Jérôme Benathan | M | - | 11 years | |
| Lay Khiam Ong | M | 76 | 5 years | |
| Simon Wespi | M | - | 12 years | |
| André Fernandes Lopes Dias | M | - | 3 years | |
| Nimesh Patel | M | 47 | 7 years | |
| Edward Kaufman | M | - | 4 years | |
| Richard Samuelson | M | - | 14 years | |
| Marc Mächler | M | 54 | 7 years | |
| Christoph Kanneberger | M | - | 3 years | |
| Patryk Nowakowski | M | 45 | 3 years | |
| Thomas Hallam | M | 58 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | - |
| Roland Leuenberger | M | 56 | 2 years | |
| William Greenberg | M | 56 | 4 years | |
| Simone Westerfeld | M | 49 | 6 years | |
| John Laurens Troost | M | 56 | 7 years | |
| Hong Ping Cai | M | 70 | 4 years | |
| Barbara Artmann | F | 63 | 4 years | |
| Man Yu Cheung | M | 49 | 3 years | |
| Richard O. Ebner | M | - | 2 years | |
| Riccardo Boscardin | M | 72 | 12 years | |
| Andrea Buscaglia | M | 60 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 7 years |
| Hans-Ulrich Meister | M | 65 | 2 years | |
| Thomas Konrad Escher | M | 75 | - | |
| Alberto Togni | M | 84 | 7 years | |
| Oswald J. Grübel | M | 80 | 2 years | |
| Kevin O'Shea | M | 58 | 6 years | |
| Luzius Cameron | M | 68 | - | |
| Rolf A. Meyer | M | 80 | 10 years | |
| Marco Suter | M | 66 | 34 years | |
| Stephan Haeringer | M | 77 | - | |
| Marcel Ospel | M | 74 | 7 years | |
| Jacques Theurillat | M | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 years |
| John Cryan | M | 63 | 3 years | |
| Clive Standish | M | 71 | 5 years | |
| Jeffrey Diermeier | M | 71 | 4 years | |
| Leonard Patrick Gage | M | 81 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 3 years |
| Larry Weinbach | M | 84 | 7 years | |
| Gabrielle Kaufmann-Kohler | F | 71 | - | |
| Thomas Lynch | M | 56 | 1 years | |
| Ann Godbehere | F | 69 | - | |
| Bernard Mach | M | 90 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 10 years |
| David Aufhauser | M | - | - | |
| Alan Charles Hodson | M | 62 | - | |
| Melanie Gee | F | 63 | 9 years | |
| Olav Noack | M | 56 | 5 years | |
| David Sidwell | M | 71 | - | |
| Andrew Look | M | 59 | 8 years | |
| Michèle Ollier | M | 65 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 2 years |
| Marcel Rohner | M | 60 | 2 years | |
| Philip Atanasov Pashov | M | - | 4 years | |
| Fereydoun Firouz | M | 61 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | - |
| Hans Thierstein | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 25 years |
| Greg Bohlen | M | 65 | 2 years | |
| Jörg Wolfgang Wolle | M | 67 | 3 years | |
| Djan Yagtug | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | - |
| Andrew Galazka | M | 69 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | - |
| Stuart R. Grant | M | 69 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 12 years |
| Giampiero de Luca | M | 70 |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 19 years |
| Leon Bushara | M | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | 14 years |
| Streiff Tom | M | - | 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 96 | 96.00% |
| United Kingdom | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ernesto Bertarelli
- Personal Network